NCT04664504 2021-06-08
A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk
ChineseAMS
Phase 2 Unknown
Clinical Trials
10 trialsNCT04747951 2021-02-15
Total Neoadjuvant Therapy in Rectal Cancer Treatment
State Scientific Centre of Coloproctology, Russian Federation
Phase 4 Unknown
NCT01047969 2019-06-13
Avoiding Surgery in Rectal Cancer After Pre-Operative Therapy
Royal Marsden NHS Foundation Trust
Phase 2 Unknown
NCT03177382 2018-05-08
TNTCRT
West China Hospital
Phase 3 Unknown
NCT00482222 2013-01-23
Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer
University of Southampton
Phase 3 Unknown
NCT00438737 2011-09-02
Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00006479 2011-04-18
Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00383695 2010-01-13
EXPERT-C
Royal Marsden NHS Foundation Trust
Phase 2 Unknown
NCT00513266 2009-08-07
Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00072553 2009-02-09
Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
National Cancer Institute (NCI)
Phase 2 Unknown